Macular Degeneration Clinical Trials

A listing of Macular Degeneration medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Arizona

UPDATED

Phoenix Arizona 85020

A Phase 2 clinical study for patients with Geographic Atrophy or Macular Degeneration

UPDATED

Phoenix Arizona 85014

A Phase 2 clinical study for patients with Geographic Atrophy or Macular Degeneration

Gilbert Arizona 85295

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Gilbert Arizona

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

Phoenix Arizona 85014

A clinical research study of Fovista®, Bevacizumab, Ranibizumab and Aflibercept for the treatment of Age-Related Macular Degeneration

View More ▼

Phoenix Arizona 85014

A clinical research study of Ranibizumab ITV injection and Ranibizumab through RPDS Implant for the treatment of Age-Related Macular Degeneration

Phoenix Arizona

A clinical research study of X-82, Aflibercept and Placebo

Phoenix Arizona

A clinical trial to evaluate treatments using DE-120 and Aflibercept for patients with Age-Related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Phoenix Arizona

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Phoenix Arizona 85012

A clinical trial to evaluate treatments using RG7716 and Ranibizumab for patients with Age-Related Macular Degeneration (AMD), Choroidal Neovascularization

Phoenix Arizona 85020

A Phase 1/Phase 2 clinical study for patients with Macular Degeneration, Age-related Macular Degeneration (AMD)

Phoenix Arizona 85014

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Tucson Arizona 85710

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Tucson Arizona 85704

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Tucson Arizona

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

California

UPDATED

La Jolla California 92093-0946

A Phase 2 clinical study for patients with Geographic Atrophy or Macular Degeneration

UPDATED

Mountain View California 94040

A Phase 2 clinical study for patients with Geographic Atrophy or Macular Degeneration

Arcadia California

A clinical trial to evaluate treatments using DS-7080a and Ranibizumab for patients with Neovascular Age-Related Macular Degeneration

Arcadia California

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Bakersfield California 93309

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

View More ▼

Bakersfield California

A clinical trial to evaluate treatments using DE-120 and Aflibercept for patients with Age-Related Macular Degeneration

Bakersfield California 93309

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Beverly Hills California 90211

A clinical research study of Fovista®, Bevacizumab, Ranibizumab and Aflibercept for the treatment of Age-Related Macular Degeneration

Beverly Hills California

A clinical research study of X-82, Aflibercept and Placebo

Beverly Hills California 90211

A clinical trial seeking patients for a research study for the treatment of Dry Macular Degeneration or Geographic Atrophy

Beverly Hills California 90211

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Beverly Hills California

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Beverly Hills California 90211

A Phase 1/Phase 2 clinical study for patients with Macular Degeneration, Age-related Macular Degeneration (AMD)

Beverly Hills California 90211

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Beverly Hills California 90211

Patients are needed to participate in a clinical research study evaluating APL-2 for the treatment of Neovascular Age-Related Macular Degeneration

Beverly Hills California

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Campbell California 95008

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Campbell California 95008

A clinical trial to evaluate treatments using No Intervention for patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima A)

Fresno California 93720

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Fullerton California 92835

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Fullerton California 92835

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Irvine California 92697

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Irvine California

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Irvine California 92697

A Phase 1/Phase 2 clinical study for patients with Macular Degeneration, Age-related Macular Degeneration (AMD)

Irvine California 92697-4375

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

La Jolla California 92093

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

La Jolla California 92037

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

La Jolla California 92093

A Phase 1/Phase 2 clinical study for patients with Macular Degeneration, Age-related Macular Degeneration (AMD)

Los Angeles California 90095

A clinical research study of Microplasmin and Placebo control for the treatment of Macular Degeneration

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Dry Macular Degeneration or Geographic Atrophy

Los Angeles California 90095

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Los Angeles California 90095-7000

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy